<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Surg Today</journal-id><journal-id journal-id-type="iso-abbrev">Surg Today</journal-id><journal-title-group><journal-title>Surgery Today</journal-title></journal-title-group><issn pub-type="ppub">0941-1291</issn><issn pub-type="epub">1436-2813</issn><publisher><publisher-name>Springer Nature Singapore</publisher-name><publisher-loc>Singapore</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38842555</article-id><article-id pub-id-type="pmc">PMC11499436</article-id>
<article-id pub-id-type="publisher-id">2871</article-id><article-id pub-id-type="doi">10.1007/s00595-024-02871-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Intraoperative neuromonitoring during thyroidectomy does not decrease vocal cord palsy risk, but the cumulative experience of the surgeon may</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Bae</surname><given-names>Hye Lim</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Oh</surname><given-names>Moon Young</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Han</surname><given-names>Mira</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Che-Wei</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Chai</surname><given-names>Young Jun</given-names></name><address><email>kevinjoon@naver.com</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04h9pn542</institution-id><institution-id institution-id-type="GRID">grid.31501.36</institution-id><institution-id institution-id-type="ISNI">0000 0004 0470 5905</institution-id><institution>Department of Surgery, </institution><institution>Seoul National University College of Medicine, Seoul National University Hospital, </institution></institution-wrap>Seoul, Korea </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04h9pn542</institution-id><institution-id institution-id-type="GRID">grid.31501.36</institution-id><institution-id institution-id-type="ISNI">0000 0004 0470 5905</institution-id><institution>Department of Surgery, </institution><institution>Seoul National University College of Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, </institution></institution-wrap>Seoul, Korea </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/002wfgr58</institution-id><institution-id institution-id-type="GRID">grid.484628.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 0943 2764</institution-id><institution>Medical Research Collaborating Center, </institution><institution>Seoul Metropolitan Government Seoul National University Boramae Medical Center, </institution></institution-wrap>Seoul, Korea </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02xmkec90</institution-id><institution-id institution-id-type="GRID">grid.412027.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0620 9374</institution-id><institution>Department of Otorhinolaryngology&#x02014;Head and Neck Surgery, </institution><institution>Kaohsiung Medical University Hospital, </institution></institution-wrap>Kaohsiung, Taiwan </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01z4nnt86</institution-id><institution-id institution-id-type="GRID">grid.412484.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 0302 820X</institution-id><institution>Transdisciplinary Department of Medicine and Advanced Technology, </institution><institution>Seoul National University Hospital, </institution></institution-wrap>Seoul, Korea </aff></contrib-group><pub-date pub-type="epub"><day>6</day><month>6</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>6</day><month>6</month><year>2024</year></pub-date><pub-date pub-type="ppub"><year>2024</year></pub-date><volume>54</volume><issue>11</issue><fpage>1401</fpage><lpage>1409</lpage><history><date date-type="received"><day>26</day><month>2</month><year>2024</year></date><date date-type="accepted"><day>7</day><month>4</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024, corrected publication 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Purpose</title><p id="Par1">To evaluate the influence of intraoperative neuromonitoring (IONM) on vocal cord palsy (VCP) rates and assess the temporal trends in VCP rates.</p></sec><sec><title>Methods</title><p id="Par2">The subjects of this retrospective study were patients who underwent thyroidectomy for thyroid cancer between March, 2014 and June, 2022, at a university hospital in Korea. We compared VCP rates between the non-IONM and IONM groups and analyzed the risk factors for VCP and VCP rates over time.</p></sec><sec><title>Results</title><p id="Par3">A total of 712 patients were included in the analysis. The rates of transient and permanent VCP did not differ significantly between the non-IONM and IONM groups. Transient VCP occurred in 4.6% and 4.3% patients (<italic>p</italic>&#x02009;=&#x02009;0.878) and VCP was permanent in 0.7% and 0.4% patients (<italic>p</italic>&#x02009;=&#x02009;0.607) in the non-IONM and IONM groups, respectively. Among the nerves at risk, transient damage occurred in 2.8% and 3.0% patients (<italic>p</italic>&#x02009;=&#x02009;0.901), and permanent damage occurred in 0.4% and 0.3% (<italic>p</italic>&#x02009;=&#x02009;0.688), respectively. Multivariate analysis revealed no significant risk factors for VCP. There was a significant decreasing trend in VCP rates over time as the cumulative number of cases increased (<italic>p</italic>&#x02009;=&#x02009;0.017).</p></sec><sec><title>Conclusions</title><p id="Par4">IONM did not reduce the risk of VCP significantly. However, the declining trend of VCP rates suggests that the surgeon&#x02019;s experience may mitigate VCP risk.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Intraoperative neuromonitoring</kwd><kwd>Risk factors</kwd><kwd>Thyroid cancer</kwd><kwd>Thyroidectomy</kwd><kwd>Vocal cord palsy</kwd></kwd-group><funding-group><award-group><funding-source><institution>Seoul National University Hospital</institution></funding-source></award-group><open-access><p>Open Access funding enabled and organized by Seoul National University Hospital.</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Japan Surgical Society 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par5">The recurrent laryngeal nerve (RLN) branches off the vagus nerve (VN) and follows a course adjacent to the medial side of the thyroid along the tracheoesophageal groove [<xref ref-type="bibr" rid="CR1">1</xref>]. RLN injury is a major complication associated with thyroidectomy [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. RLN injury can lead to impaired movement of the vocal cords, known as vocal cord palsy (VCP), causing symptoms, such as hoarseness, increased risk of aspiration, and breathing difficulties [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par6">To preserve the RLN during thyroidectomy, various techniques and devices have been introduced, including intermittent intraoperative nerve monitoring (IONM) [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. IONM involves stimulating either the RLN or VN during thyroidectomy, converting vocal cord muscle movement into an electronic response and recording the evoked electromyographic signal, thereby aiding in the identifying the nerve [<xref ref-type="bibr" rid="CR7">7</xref>]. However, there is controversy about whether IONM effectively reduces VCP rates. While some studies suggest that IONM can lower the incidence of VCP and predict the extent of nerve damage after thyroidectomy [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>], others report no significant difference in VCP rates between patients who undergo IONM and those who do not [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>] Moreover, the retrospective nature of these studies makes them susceptible to selection bias, as IONM is used more frequently in patients at higher risk of RLN injury [<xref ref-type="bibr" rid="CR12">12</xref>].</p><p id="Par7">The introduction and adoption of IONM vary among healthcare organizations and regions [<xref ref-type="bibr" rid="CR13">13</xref>]. Inconsistencies in the availability and cost of IONM are attributed to differences in healthcare systems and health insurance coverage [<xref ref-type="bibr" rid="CR14">14</xref>]. In Korea, the utilization of IONM was previously limited by a lack of national health insurance coverage; however, since December, 2016, IONM has been covered by national health insurance, leading to rapid expansion of its usage. This allowed us to conduct a study in which patients were assigned to surgical groups (non-IONM vs. IONM) based on their date of surgery rather than the surgeon&#x02019;s preference or patient-related factors, thereby reducing selection bias. The objective of this study was to evaluate the effectiveness of IONM in preventing VCP and to identify the factors associated with VCP in patients undergoing thyroidectomy, stratified by the date of surgery.</p></sec><sec id="Sec2"><title>Materials and methods</title><sec id="Sec3"><title>Study population</title><p id="Par8">A retrospective medical record analysis was conducted on consecutive patients diagnosed with thyroid carcinoma who underwent thyroidectomy at Seoul Metropolitan Government&#x02013;Seoul National University Boramae Medical Center between March, 2014 and June, 2022. All patients underwent preoperative ultrasonography and computed tomography of the neck to assess the tumor extent and lymph node status. The routine use of IONM for patients undergoing thyroidectomy at our center began in December, 2016, which coincides with the national health insurance coverage for IONM. Thus, patients who underwent thyroidectomy between March, 2014 and November, 2016 were included in the non-IONM group and those who underwent thyroidectomy between December, 2016 and June, 2022 were included in the IONM group. Patients with a previous history of neck surgery, simultaneous parathyroidectomy or thymectomy, preoperative RLN nerve invasion, or tracheal tumor invasion were excluded from the analysis. The study was approved by the Institutional Review Board of Seoul Metropolitan Government&#x02013;Seoul National University Boramae Medical Center (IRB number: 10&#x02013;2023-30), and individual consent for this retrospective analysis was waived.</p></sec><sec id="Sec4"><title>Surgical and intraoperative neuromonitoring procedures</title><p id="Par9">On induction of anesthesia, patients received lidocaine (30&#x000a0;mg), rocuronium (0.6&#x000a0;mg/kg), and a targeted-controlled continuous infusion of propofol and remifentanil. All operations were performed by a single surgeon (Y.J.C). For patients who underwent thyroidectomy without IONM, the RLNs were identified visually before and after thyroidectomy. In those who underwent thyroidectomy with IONM, standard reinforced electromyogram endotracheal tubes and the nerve integrity monitor 3.0 system (Medtronic, Jacksonville, FL, USA) were utilized, and the IONM procedure followed the standardized guidelines of the International Neural Monitoring Study Group [<xref ref-type="bibr" rid="CR15">15</xref>]. Loss of signal was defined as an RLN amplitude level lower than 100&#x000a0;&#x003bc;V during surgery.</p></sec><sec id="Sec5"><title>Postoperative evaluation</title><p id="Par10">Postoperative assessments were performed during outpatient clinic appointments and vocal cords were evaluated by laryngoscopy within 10&#x000a0;days after thyroidectomy. VCP was defined as fixed or hypomobile vocal cords observed on indirect laryngoscopy. If VCP was identified, further follow-up was conducted regularly until the palsy improved. RLN injury was categorized as &#x02018;transient&#x02019; if movement of the vocal cords recovered within 6&#x000a0;months of surgery and &#x02018;permanent&#x02019; if impairment persisted for over 6&#x000a0;months. Serum levels of total calcium and parathyroid hormone were monitored to identify postoperative hypoparathyroidism. Hypoparathyroidism was defined by laboratory findings of parathyroid hormone levels below 15.0&#x000a0;pg/ml or the need for an oral calcium preparation to treat symptoms, such as numbness or tingling sensation in the hands, feet, or face.</p></sec><sec id="Sec6"><title>Clinicopathological characteristics and surgical outcomes</title><p id="Par11">We evaluated the clinicopathological characteristics of the patients and compared the surgical outcomes of the IONM and non-IONM groups. Patient characteristics included age, gender, and body mass index (BMI), and surgical characteristics included surgical extent and extent of lymph node dissection. Histopathological characteristics included lesion location and size, multicentricity, extrathyroidal extension, histological type, number of retrieved lymph nodes, number of metastatic lymph nodes, and the presence of thyroiditis. Cancer stage was classified using the American Joint Committee on Cancer staging manual 8th edition [<xref ref-type="bibr" rid="CR16">16</xref>]. The mechanism of injury of each case of VCP was based on the operative records and categorized into five types: traction injury, crush injury, transection injury, thermal injury, and undetermined [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. VCP was further classified as caused by either RLN or VN injury.</p></sec><sec id="Sec7"><title>Statistical analysis</title><p id="Par12">Patient characteristics are presented as frequencies with percentages for categorical variables and as the mean&#x02009;&#x000b1;&#x02009;standard deviation or median with interquartile range for continuous variables. Continuous variables were compared using the <italic>t</italic> test or Mann&#x02013;Whitney <italic>U</italic> test, whereas categorical variables were compared using the Chi-square or Fisher&#x02019;s exact tests. Risk factors associated with VCP were examined using univariate logistic regression models and then considered for inclusion in the multivariable logistic regression model if significant (<italic>p</italic> value&#x02009;&#x0003c;&#x02009;0.1). The trend of the VCP rate over time was analyzed using the Cochran&#x02013;Armitage trend test. Statistical analyses were performed using SAS version 9.4 (SAS Institute Inc., Cary, NC) and R version 4.2.2 (R foundation for Statistical Computing, Vienna, Austria).&#x000a0;Except for the inclusion criteria of <italic>p</italic> less than 0.1 used for the multivariate logistic regression model, <italic>p</italic> values less than 0.05 were considered significant.</p></sec></sec><sec id="Sec8"><title>Results</title><sec id="Sec9"><title>Clinical characteristics</title><p id="Par13">A total of 748 patients underwent thyroidectomy between March, 2014 and June, 2022. After the exclusion of 36 patients, 712 patients (485 female and 227 male) were included in the analysis (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Table <xref rid="Tab1" ref-type="table">1</xref> summarizes the clinicopathological characteristics of the included patients. The mean age was 52.6&#x000a0;years and the mean BMI was 25.3&#x000a0;kg/m<sup>2</sup>. The non-IONM group comprised 151 patients and the IONM group comprised 561 patients. There were no significant differences in patient characteristics between the groups, including sex, age, and BMI. Lobectomy and total thyroidectomy were performed in 56 (37.1%) and 95 (62.9%) patients, respectively, in the non-IONM group, while 322 (57.4%) and 239 (42.6%) patients underwent lobectomy and total thyroidectomy, respectively, in the IONM group (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001). The non-IONM group had a higher proportion of central node dissection than the IONM group (98.0% vs. 93.2%, <italic>p</italic>&#x02009;=&#x02009;0.025). The non-IONM group was associated with lower T stages, whereas the IONM group was associated with higher T stages (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001). There were no differences in other surgical or histopathological characteristics between the groups. Final pathology included 688 (93.8%) papillary thyroid carcinomas, 31 (4.4%) follicular thyroid carcinomas, 5 (0.7%) oncocytic carcinomas, 4 (0.6%) medullary thyroid carcinomas, 2 (0.3%) poorly differentiated thyroid carcinomas, and 2 (0.3%) anaplastic carcinomas.<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Flow diagram of included patients. After exclusion, 712 patients (151 non-IONM and 561 IONM) and 1046 nerves at risk (246 non-IONM and 800 IONM) were included in the study. <italic>IONM</italic> intraoperative neuromonitoring</p></caption><graphic xlink:href="595_2024_2871_Fig1_HTML" id="MO1"/></fig><table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Clinicopathological characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Variables</th><th align="left">Total (<italic>n</italic>&#x02009;=&#x02009;712)</th><th align="left">Non-IONM (<italic>n</italic>&#x02009;=&#x02009;151)</th><th align="left">IONM (<italic>n</italic>&#x02009;=&#x02009;561)</th><th align="left"><italic>p</italic> value</th></tr></thead><tbody><tr><td align="left"><italic>Sex</italic></td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Female</td><td align="left">485 (68.1)</td><td align="left">108 (71.5)</td><td align="left">377 (67.2)</td><td align="left">0.312<sup>1</sup></td></tr><tr><td align="left">Male</td><td align="left">227 (31.9)</td><td align="left">43 (28.5)</td><td align="left">184 (32.8)</td><td align="left"/></tr><tr><td align="left">Age (years)</td><td align="left">52.6&#x02009;&#x000b1;&#x02009;13.1</td><td align="left">51.8&#x02009;&#x000b1;&#x02009;13.9</td><td align="left">52.8&#x02009;&#x000b1;&#x02009;12.9</td><td align="left">0.408<sup>3</sup></td></tr><tr><td align="left">Body mass index (kg/m<sup>2</sup>) (N&#x02009;=&#x02009;707)</td><td align="left">25.3&#x02009;&#x000b1;&#x02009;4.0</td><td align="left">25.0&#x02009;&#x000b1;&#x02009;3.4</td><td align="left">25.4&#x02009;&#x000b1;&#x02009;4.2</td><td align="left">0.237<sup>3</sup></td></tr><tr><td align="left"><italic>Tumor location</italic></td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Right</td><td align="left">307 (43.1)</td><td align="left">66 (43.7)</td><td align="left">241 (43.0)</td><td align="left">0.499<sup>1</sup></td></tr><tr><td align="left">Left</td><td align="left">274 (38.5)</td><td align="left">62 (41.1)</td><td align="left">212 (37.8)</td><td align="left"/></tr><tr><td align="left">Bilateral</td><td align="left">131 (18.4)</td><td align="left">23 (15.2)</td><td align="left">108 (19.3)</td><td align="left"/></tr><tr><td align="left"><italic>Surgical extent</italic></td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Lobectomy</td><td align="left">378 (53.1)</td><td align="left">56 (37.1)</td><td align="left">322 (57.4)</td><td align="left">&#x02009;&#x0003c;&#x02009;.0001<sup>1</sup></td></tr><tr><td align="left">Total thyroidectomy</td><td align="left">334 (46.9)</td><td align="left">95 (62.9)</td><td align="left">239 (42.6)</td><td align="left"/></tr><tr><td align="left"><italic>Central node dissection</italic></td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Not Done</td><td align="left">41 (5.8)</td><td align="left">3 (2.0)</td><td align="left">38 (6.8)</td><td align="left">0.025<sup>1</sup></td></tr><tr><td align="left">Done</td><td align="left">671 (94.2)</td><td align="left">148 (98.0)</td><td align="left">523 (93.2)</td><td align="left"/></tr><tr><td align="left"><italic>Lateral node dissection</italic></td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Not Done</td><td align="left">625 (87.8)</td><td align="left">137 (90.7)</td><td align="left">488 (87.0)</td><td align="left">0.213<sup>1</sup></td></tr><tr><td align="left">Done</td><td align="left">87 (12.2)</td><td align="left">14 (9.3)</td><td align="left">73 (13.0)</td><td align="left"/></tr><tr><td align="left"><italic>Thyroid cancer pathology</italic></td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Papillary thyroid carcinoma</td><td align="left">688 (93.8)</td><td align="left">146 (96.7)</td><td align="left">522 (93.0)</td><td align="left">0.253<sup>2</sup></td></tr><tr><td align="left">Follicular thyroid carcinoma</td><td align="left">31 (4.4)</td><td align="left">3 (2.0)</td><td align="left">28 (5.0)</td><td align="left"/></tr><tr><td align="left">Oncocytic carcinoma</td><td align="left">5 (0.7)</td><td align="left">0 (0.0)</td><td align="left">5 (0.9)</td><td align="left"/></tr><tr><td align="left">Medullary thyroid carcinoma</td><td align="left">4 (0.6)</td><td align="left">2 (1.3)</td><td align="left">2 (0.4)</td><td align="left"/></tr><tr><td align="left">Poorly differentiated thyroid carcinoma</td><td align="left">2 (0.3)</td><td align="left">0 (0.0)</td><td align="left">2 (0.4)</td><td align="left"/></tr><tr><td align="left">Anaplastic thyroid carcinoma</td><td align="left">2 (0.3)</td><td align="left">0 (0.0)</td><td align="left">2 (0.4)</td><td align="left"/></tr><tr><td align="left"><italic>T stage</italic></td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">T1</td><td align="left">580 (81.5)</td><td align="left">134 (88.7)</td><td align="left">446 (79.5)</td><td align="left">0.001<sup>1</sup></td></tr><tr><td align="left">T2</td><td align="left">67 (9.4)</td><td align="left">15 (9.9)</td><td align="left">52 (9.3)</td><td align="left"/></tr><tr><td align="left">T3 or more</td><td align="left">65 (9.1)</td><td align="left">2 (1.3)</td><td align="left">63 (11.2)</td><td align="left"/></tr><tr><td align="left"><italic>N stage</italic></td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">N0</td><td align="left">420 (59.0)</td><td align="left">87 (57.6)</td><td align="left">333 (59.4)</td><td align="left">0.214<sup>1</sup></td></tr><tr><td align="left">N1a</td><td align="left">203 (28.5)</td><td align="left">50 (33.1)</td><td align="left">153 (27.3)</td><td align="left"/></tr><tr><td align="left">N1b</td><td align="left">89 (12.5)</td><td align="left">14 (9.3)</td><td align="left">75 (13.4)</td><td align="left"/></tr><tr><td align="left">Harvested lymph nodes (<italic>n</italic>)</td><td align="left">8.4&#x02009;&#x000b1;&#x02009;11.2</td><td align="left">5.0 (2.0&#x02013;9.0)</td><td align="left">5.0 (2.0&#x02013;10.0)</td><td align="left">0.631<sup>4</sup></td></tr><tr><td align="left"><italic>Multifocality</italic></td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Single</td><td align="left">494 (69.4)</td><td align="left">104 (68.9)</td><td align="left">390 (69.5)</td><td align="left">0.879<sup>1</sup></td></tr><tr><td align="left">Multifocal</td><td align="left">218 (30.6)</td><td align="left">47 (31.1)</td><td align="left">171 (30.5)</td><td align="left"/></tr><tr><td align="left"><italic>Extrathyroidal extension</italic></td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">None</td><td align="left">656 (92.1)</td><td align="left">139 (92.1)</td><td align="left">517 (92.2)</td><td align="left">0.966<sup>1</sup></td></tr><tr><td align="left">Gross</td><td align="left">56 (7.9)</td><td align="left">12 (7.9)</td><td align="left">44 (7.8)</td><td align="left"/></tr><tr><td align="left"><italic>Thyroiditis</italic></td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">No</td><td align="left">524 (73.6)</td><td align="left">111 (73.5)</td><td align="left">413 (73.6)</td><td align="left">0.979<sup>1</sup></td></tr><tr><td align="left">Yes</td><td align="left">188 (26.4)</td><td align="left">40 (26.5)</td><td align="left">148 (26.4)</td><td align="left"/></tr></tbody></table><table-wrap-foot><p>Values are expressed as <italic>n</italic> (%) or mean&#x02009;&#x000b1;&#x02009;standard deviation</p><p><sup>1</sup>Chi-square test</p><p><sup>2</sup>Fisher&#x02019;s exact test</p><p><sup>3</sup><italic>&#x000a0;T</italic> test</p><p><sup>4</sup>Wilcoxon rank sum test</p><p><italic>IONM</italic> Intraoperative nerve monitoring, <italic>CND</italic> Central node dissection, <italic>LND</italic> Lateral node dissection</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec10"><title>Postoperative surgical complications</title><p id="Par14">Table <xref rid="Tab2" ref-type="table">2</xref> lists the postoperative complications in the non-IONM and IONM groups. There were no significant differences between the groups. Transient VCP occurred in 7/151 (4.6%) non-IONM patients and 24/561 (4.3%) IONM patients (<italic>p</italic>&#x02009;=&#x02009;0.878), and permanent VCP occurred in 1/151 (0.7%) non-IONM patients and 2/561 (0.4%) IONM patients (<italic>p</italic>&#x02009;=&#x02009;0.607). A total of 1,046 at-risk nerves were included in the analysis. Among them, transient VCP occurred in 7/246 (2.8%) nerves at-risk in the non-IONM group and 24/800 (3.0%) nerves at-risk in the IONM group (<italic>p</italic>&#x02009;=&#x02009;0.901), and permanent VCP occurred in 1/246 (0.4%) nerves at-risk in the non-IONM group and 2/800 (0.3%) nerves at-risk in the IONM group (<italic>p</italic>&#x02009;=&#x02009;0.688). There were no cases of bilateral VCP in either group and no significant differences in other postoperative complications between the groups.<table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Postoperative complications in the non-intraoperative nerve monitoring and the intraoperative nerve monitoring groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Variables</th><th align="left">Non-IONM (<italic>n</italic>&#x02009;=&#x02009;151, nerves at risk&#x02009;=&#x02009;246)</th><th align="left">IONM (<italic>n</italic>&#x02009;=&#x02009;561, nerves at risk&#x02009;=&#x02009;800)</th><th align="left"><italic>p</italic> value</th></tr></thead><tbody><tr><td align="left"><italic>VCP</italic></td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Transient VCP</td><td align="left">7 (4.6) / (2.8)*</td><td align="left">24 (4.3) / (3.0)*</td><td align="left">0.848 / 0.901*</td></tr><tr><td align="left">Permanent VCP</td><td align="left">1 (0.7) / (0.4)*</td><td align="left">2 (0.4) / (0.3)*</td><td align="left">0.607 / 0.688*</td></tr><tr><td align="left"><italic>Hypoparathyroidism</italic></td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Transient hypoparathyroidism</td><td align="left">5 (3.3)</td><td align="left">35 (6.2)</td><td align="left">0.166</td></tr><tr><td align="left">Permanent hypoparathyroidism</td><td align="left">2 (1.3)</td><td align="left">6 (1.1)</td><td align="left">0.792</td></tr><tr><td align="left">Postoperative bleeding</td><td align="left">0 (0.0)</td><td align="left">6 (1.1)</td><td align="left">0.202</td></tr><tr><td align="left">Wound infection</td><td align="left">2 (1.3)</td><td align="left">2 (0.4)</td><td align="left">0.158</td></tr><tr><td align="left">Deep neck infection</td><td align="left">0 (0.0)</td><td align="left">1 (0.2)</td><td align="left">0.604</td></tr><tr><td align="left">Chyle leakage</td><td align="left">0 (0.0)</td><td align="left">2 (0.4)</td><td align="left">0.462</td></tr><tr><td align="left">Trachea injury</td><td align="left">0 (0.0)</td><td align="left">0 (0.0)</td><td align="left">N/A</td></tr></tbody></table><table-wrap-foot><p>Values are expressed as <italic>n</italic> (%) or mean&#x02009;&#x000b1;&#x02009;standard deviation</p><p><italic>IONM</italic> Intraoperative nerve monitoring, <italic>VCP</italic> vocal cord palsy, <italic>N/A</italic> not applicable</p><p>*Percentage for nerves at risk</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec11"><title>VCP trend analysis</title><p id="Par15">Figure&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref> summarizes the annual frequency and rate of VCP, pooling both transient and permanent VCP. Between 2014 and 2022, the total mean VCP rate was 4.8% and the annual VCP rates were 8.9%, 2.1%, 10.0%, 9.7%, 5.3, 3.1%, 4.2%, 2.8%, and 1.7%, respectively. As the number of cumulative cases increased over time, there was a significant decreasing trend in annual VCP rates (<italic>p</italic>&#x02009;=&#x02009;0.017).<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Annual vocal cord palsy rates over time. Summary of the vocal cord palsy rates (transient and permanent combined) over time. The graph shows a significant decreasing trend in vocal cord palsy rates over time as the number of cases increased (<italic>p</italic>&#x02009;=&#x02009;0.017). <italic>VCP</italic> vocal cord palsy</p></caption><graphic xlink:href="595_2024_2871_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec12"><title>Risk factors for vocal cord palsy</title><p id="Par16">Table <xref rid="Tab3" ref-type="table">3</xref> shows the results of the risk factor analysis for VCP. In the univariate analysis, N1b stage (odds ratio [OR] 3.038, 95% confidence interval [CI] 1.285&#x02013;7.182, <italic>p</italic>&#x02009;=&#x02009;0.011) and extrathyroidal extension (OR 2.691, 95% CI 1.064&#x02013;6.805, <italic>p</italic>&#x02009;=&#x02009;0.036) were identified as significant risk factors for VCP. Four predictor variables (use of IONM, surgical extent, N stage, and extrathyroidal extension) were included in the multivariate analysis, which did not identify any significant risk factors for VCP.<table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>Risk factor analysis for vocal cord palsy</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Variables</th><th align="left" rowspan="2">Category</th><th align="left" rowspan="2"><italic>N</italic></th><th align="left" rowspan="2">E</th><th align="left" colspan="2">Univariate</th><th align="left" colspan="2">Multivariate</th></tr><tr><th align="left">OR (95% CI)</th><th align="left"><italic>p</italic> value</th><th align="left">OR (95% CI)</th><th align="left"><italic>p</italic> value</th></tr></thead><tbody><tr><td align="left"><italic>Sex</italic></td><td align="left">Female</td><td align="left">485</td><td align="left">19</td><td align="left">Ref</td><td char="." align="char"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left"/><td align="left">Male</td><td align="left">227</td><td align="left">15</td><td align="left">1.735 (0.865&#x02013;3.481)</td><td char="." align="char">0.121</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left">Age (year)</td><td align="left"/><td align="left">712</td><td align="left">34</td><td align="left">0.988 (0.963&#x02013;1.015)</td><td char="." align="char">0.381</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left">Body mass index (kg/m<sup>2</sup>)</td><td align="left"/><td align="left">707</td><td align="left">34</td><td align="left">1.021 (0.939&#x02013;1.111)</td><td char="." align="char">0.626</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left"><italic>Tumor location</italic></td><td align="left">Right</td><td align="left">307</td><td align="left">12</td><td align="left">Ref</td><td char="." align="char"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left"/><td align="left">Left</td><td align="left">274</td><td align="left">16</td><td align="left">1.525 (0.708&#x02013;3.282)</td><td char="." align="char">0.281</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left"/><td align="left">Bilateral</td><td align="left">131</td><td align="left">6</td><td align="left">1.180 (0.433&#x02013;3.214)</td><td char="." align="char">0.746</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left"><italic>Surgical extent</italic></td><td align="left">Lobectomy</td><td align="left">378</td><td align="left">13</td><td align="left">Ref</td><td char="." align="char"/><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left"/><td align="left">Total thyroidectomy</td><td align="left">334</td><td align="left">21</td><td align="left">1.884 (0.928&#x02013;3.824)</td><td char="." align="char">0.080</td><td align="left">1.328 (0.587&#x02013;3.003)</td><td char="." align="char">0.496</td></tr><tr><td align="left"><italic>IONM use</italic></td><td align="left">Non-IONM</td><td align="left">151</td><td align="left">8</td><td align="left">Ref</td><td char="." align="char"/><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left"/><td align="left">IONM</td><td align="left">561</td><td align="left">26</td><td align="left">0.869 (0.385&#x02013;1.960)</td><td char="." align="char">0.735</td><td align="left">0.886 (0.383&#x02013;2.048)</td><td char="." align="char">0.777</td></tr><tr><td align="left"><italic>T stage</italic></td><td align="left">T1</td><td align="left">580</td><td align="left">24</td><td align="left">Ref</td><td char="." align="char"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left"/><td align="left">T2</td><td align="left">67</td><td align="left">6</td><td align="left">2.279 (0.897&#x02013;5.793)</td><td char="." align="char">0.084</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left"/><td align="left">T3 or more</td><td align="left">65</td><td align="left">4</td><td align="left">1.519 (0.510&#x02013;4.523)</td><td char="." align="char">0.453</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left"><italic>N stage</italic></td><td align="left">N0</td><td align="left">420</td><td align="left">15</td><td align="left">Ref</td><td char="." align="char"/><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left"/><td align="left">N1a</td><td align="left">203</td><td align="left">10</td><td align="left">1.399 (0.617&#x02013;3.171)</td><td char="." align="char">0.421</td><td align="left">1.284 (0.560&#x02013;2.942)</td><td char="." align="char">0.555</td></tr><tr><td align="left"/><td align="left">N1b</td><td align="left">89</td><td align="left">9</td><td align="left">3.038 (1.285&#x02013;7.182)</td><td char="." align="char">0.011</td><td align="left">2.245 (0.832&#x02013;6.060)</td><td char="." align="char">0.110</td></tr><tr><td align="left"><italic>Multifocality</italic></td><td align="left">Single</td><td align="left">464</td><td align="left">24</td><td align="left">Ref</td><td char="." align="char"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left"/><td align="left">Multifocal</td><td align="left">218</td><td align="left">10</td><td align="left">0.942 (0.442&#x02013;2.004)</td><td char="." align="char">0.876</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left"><italic>Extrathyroidal extension</italic></td><td align="left">No</td><td align="left">656</td><td align="left">28</td><td align="left">Ref</td><td char="." align="char"/><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left"/><td align="left">Yes</td><td align="left">56</td><td align="left">6</td><td align="left">2.691 (1.064&#x02013;6.805)</td><td char="." align="char"/><td align="left">1.945 (0.730&#x02013;5.183)</td><td char="." align="char">0.183</td></tr><tr><td align="left"><italic>Thyroiditis</italic></td><td align="left">No</td><td align="left">524</td><td align="left">22</td><td align="left">Ref</td><td char="." align="char">0.036</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left"/><td align="left">Yes</td><td align="left">188</td><td align="left">12</td><td align="left">1.556 (0.754&#x02013;3.209)</td><td char="." align="char">0.232</td><td align="left"/><td char="." align="char"/></tr></tbody></table><table-wrap-foot><p><italic>N</italic> number of patients, <italic>E</italic> events, <italic>OR</italic> odds ratio, <italic>CI</italic> confidence interval, <italic>IONM</italic> Intraoperative nerve monitoring</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec13"><title>Mechanism of recurrent laryngeal nerve injury</title><p id="Par17">Table <xref rid="Tab4" ref-type="table">4</xref> summarizes the types of VCP and their probable mechanisms of injury. In the non-IONM group, there were seven cases of transient VCP and one case of permanent VCP, the mechanisms of injury of which were undetermined. In the IONM group, there were 24 RLN injuries causing transient VCP. They included 22 traction injuries, 1 crush injury, and 1 partial transection injury. There were also two cases of VN injury in the IONM group, with one traction injury resulting in transient VCP and other one thermal injury leading to permanent VCP.<table-wrap id="Tab4"><label>Table&#x000a0;4</label><caption><p>Types of vocal cord palsy and mechanisms of injury</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Patients</th><th align="left" colspan="2">Types of mechanism</th><th align="left">Transient VCP (<italic>N</italic>&#x02009;=&#x02009;31)</th><th align="left">Permanent VCP (<italic>N</italic>&#x02009;=&#x02009;3)</th></tr><tr><th align="left">Non-IONM</th><th align="left">Undetermined (<italic>N</italic>&#x02009;=&#x02009;8)</th><th align="left"/><th align="left">7</th><th align="left">1</th></tr></thead><tbody><tr><td align="left" rowspan="5">IONM</td><td align="left" rowspan="3">RLN Injury (<italic>N</italic>&#x02009;=&#x02009;24)</td><td align="left">Traction injury</td><td align="left">22</td><td align="left">0</td></tr><tr><td align="left">Crush injury</td><td align="left">1</td><td align="left">0</td></tr><tr><td align="left">Thermal injury</td><td align="left">0</td><td align="left">1</td></tr><tr><td align="left" rowspan="2">VN Injury (<italic>N</italic>&#x02009;=&#x02009;2)</td><td align="left">Traction injury</td><td align="left">1</td><td align="left">0</td></tr><tr><td align="left">Partial transection injury</td><td align="left">0</td><td align="left">1</td></tr></tbody></table><table-wrap-foot><p><italic>VCP</italic> vocal cord palsy, <italic>IONM</italic> intraoperative neural monitoring, <italic>RLN</italic> recurrent laryngeal nerve, <italic>VN</italic> vagus nerve</p></table-wrap-foot></table-wrap></p></sec></sec><sec id="Sec14"><title>Discussion</title><p id="Par18">This study was conducted to evaluate the impact of IONM on VCP rates and identify other factors that may influence the risk of VCP. We found no significant differences in VCP rates between the non-IONM and IONM groups, suggesting that the use of IONM is not associated with a lower risk of VCP. Moreover, no significant risk factors for VCP were identified by multivariate analysis. Instead, we observed a significant decrease in VCP rates over time, which may be linked to the surgeon&#x02019;s cumulative experience.</p><p id="Par19">One meta-analysis demonstrated that IONM minimizes the risk of VCP, and reported a significant decrease in VCP cases among IONM patients versus non-IONM patients [<xref ref-type="bibr" rid="CR9">9</xref>]. Conversely, other meta-analyses, including those that only included randomized trials, did not find significant differences in VCP rates between IONM and non-IONM groups [<xref ref-type="bibr" rid="CR19">19</xref>&#x02013;<xref ref-type="bibr" rid="CR23">23</xref>]. Previous studies have faced challenges in establishing the absolute superiority of IONM over non-IONM, potentially because of the small number of VCP events, particularly in surgeries performed by experienced surgeons in high-volume centers [<xref ref-type="bibr" rid="CR24">24</xref>&#x02013;<xref ref-type="bibr" rid="CR26">26</xref>]. One study indicated that a minimum of 9,000 at-risk RLNs needs to be analyzed in randomized controlled trials to achieve sufficient statistical power to confirm the effectiveness of IONM in preventing RLN injury [<xref ref-type="bibr" rid="CR25">25</xref>]. Another study suggested observing at least 39,907 nerves at-risk to demonstrate IONM&#x02019;s superiority over non-IONM thyroid cancer surgery [<xref ref-type="bibr" rid="CR24">24</xref>]. This study included 1,046 at-risk RLNs, which also falls short of the suggested minimum nerves at-risk. The low incidence of VCP may lead to an underestimation of the protective effect of IONM against RLN injury, and thus, the results of studies with &#x0201c;small&#x0201d; sample sizes should be interpreted with caution.</p><p id="Par20">IONM may also help identify the mechanisms of RLN injuries that occur. In this study, the probable mechanism of RLN injury was able to be determined in the IONM patients, but not in the non-IONM patients. IONM can assist in characterizing RLN injury, especially in traction or compression injuries, where the RLN appears visually intact [<xref ref-type="bibr" rid="CR18">18</xref>]. Using IONM during thyroidectomy, surgeons can modify their technique or apply other interventions to avoid repeat traction stress on the RLN and facilitate recovery. For example, if nerve function is compromised or at-risk, surgeons have options to mitigate stress on the RLN during surgery, such as administering steroids to the nerve to improve intraoperative recovery or modifying the surgical approach to the nerve [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. Although this study did not reach statistical significance on IONM&#x02019;s effectiveness in preventing nerve palsy complications, we highlight its potential value as a vital tool for surgeons, including those with substantial experience, enhancing preparedness across diverse surgical scenarios.</p><p id="Par21">This study showed a decrease in VCP rates over time with the increasing number of cases. This highlights the impact of surgical volume and experience on reducing the risk of VCP. Surgeons with higher case volumes and more experience are likely to possess advanced surgical skills and expertise in their field, leading to improved outcomes and reduced complications, including VCP [<xref ref-type="bibr" rid="CR29">29</xref>]. In fact, one study demonstrated that surgeons&#x02019; experience with IONM resulted in increased RLN identification and fewer RLN injuries, even in non-IONM thyroid surgeries, indicating the value of IONM as a tool for surgical training [<xref ref-type="bibr" rid="CR30">30</xref>]. Various studies, including both single-surgeon and multicenter studies, have also shown that a higher level of surgical experience is associated with lower rates of VCP [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR31">31</xref>&#x02013;<xref ref-type="bibr" rid="CR33">33</xref>]. Studies that implemented routine IONM for thyroid surgeries reported a decline in RLN injury rates over time [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. This study confirms the ongoing reduction in recurrent nerve palsy rates as surgeons gain more experience, even after performing over 700 operations. This highlights a continual learning process in which nerve-related complications become less frequent over time, underscoring the importance of accumulating surgical skills. In real surgical settings, nerve paralysis can arise in simple as well as complex cases, such as those with variations in the recurrent laryngeal nerve or challenges during dissection, caused by thyroiditis. As surgeons accumulate experience, they become more proficient at averting nerve paralysis issues in simple or less demanding situations. Moreover, growing expertise enables surgeons to be more prepared to adeptly handle complex cases. Consistent with previous research, this study demonstrated that surgical experience using IONM (reflected by the cumulative number of cases over time) contributed to reduced rates of VCP. Further investigation into the interplay between surgical experience, the utilization of IONM, and VCP rates may augment our understanding of the factors that influence surgical outcomes in this context.</p><p id="Par22">This study had several limitations. First, as a retrospective observational study, it is prone to inherent bias; however, adoption of the routine use of IONM at our center, which coincided with the national health insurance reimbursement, allowed us to minimize selection bias by stratifying patients based on the date of surgery rather than the surgeon&#x02019;s preference or patient factors. The fact that patients in the IONM group underwent thyroidectomy more recently than those in the non-IONM group may have influenced the results because of the learning curve effect, which should be considered when interpreting the findings. Second, the surgical extent differed between the non-IONM and IONM groups, with significantly fewer total thyroidectomy cases than lobectomy cases in the IONM group than in the non-IONM group. This difference may be attributed to the 2015 American Thyroid Association guidelines, which expanded the indications for lobectomy to nodules up to 4&#x000a0;cm in size [<xref ref-type="bibr" rid="CR34">34</xref>]. Notably, the surgical extent was not associated with the rate of VCP. Third, although this study includes 712 patients, the samples size is still insufficient to elucidate the role of IONM in reducing VCP, especially in the hands of an experienced surgeon. Finally, while this single-center, single-surgeon study may have minimized bias related to interindividual variations between surgeons, it is important to acknowledge that the data included may not be generalizable to a broader population of thyroid surgeons. Therefore, the results should be interpreted with caution considering this limitation.</p><p id="Par23">In conclusion, whereas IONM may be valuable for elucidating the mechanism of injury when nerve injury occurs, the adoption of it did not decrease the rate of VCP in patients undergoing thyroid surgery for thyroid cancer. However, there was a decrease in annual VCP rates over time with an increasing cumulative number of cases, suggesting the importance of surgical volume and the surgeon&#x02019;s experience for reducing VCP risk.</p></sec></body><back><fn-group><fn><p>The original publication has been corrected for update in the second author name.</p></fn><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Hye Lim Bae and Moon Young Oh contributed equally to this work as co-first authors.</p></fn><fn><p><bold>Change history</bold></p><p>12/19/2024</p><p>The article has been changed for update in the name of second author.</p></fn><fn><p><bold>Change history</bold></p><p>12/28/2024</p><p>A Correction to this paper has been published: 10.1007/s00595-024-02979-8</p></fn></fn-group><notes notes-type="funding-information"><title>Funding</title><p>Open Access funding enabled and organized by Seoul National University Hospital.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par24">We have no conflicts of interest to declare.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Myssiorek</surname><given-names>D</given-names></name></person-group><article-title>Recurrent laryngeal nerve paralysis: anatomy and etiology</article-title><source>Otolaryngol Clin North Am</source><year>2004</year><volume>37</volume><issue>1</issue><fpage>25</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/S0030-6665(03)00172-5</pub-id><pub-id pub-id-type="pmid">15062685</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Myssiorek D. Recurrent laryngeal nerve paralysis: anatomy and etiology. Otolaryngol Clin North Am. 2004;37(1):25&#x02013;44.<pub-id pub-id-type="pmid">15062685</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Rocke</surname><given-names>DJ</given-names></name><name><surname>Mulder</surname><given-names>H</given-names></name><name><surname>Cyr</surname><given-names>D</given-names></name><name><surname>Kahmke</surname><given-names>R</given-names></name><name><surname>Lee</surname><given-names>WT</given-names></name><name><surname>Puscas</surname><given-names>L</given-names></name><etal/></person-group><article-title>The effect of lateral neck dissection on complication rate for total thyroidectomy</article-title><source>Am J Otolaryngol</source><year>2020</year><volume>41</volume><issue>3</issue><fpage>102421</fpage><pub-id pub-id-type="doi">10.1016/j.amjoto.2020.102421</pub-id><pub-id pub-id-type="pmid">32089352</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Rocke DJ, Mulder H, Cyr D, Kahmke R, Lee WT, Puscas L, et al. The effect of lateral neck dissection on complication rate for total thyroidectomy. Am J Otolaryngol. 2020;41(3): 102421.<pub-id pub-id-type="pmid">32089352</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Rulli</surname><given-names>F</given-names></name><name><surname>Ambrogi</surname><given-names>V</given-names></name><name><surname>Dionigi</surname><given-names>G</given-names></name><name><surname>Amirhassankhani</surname><given-names>S</given-names></name><name><surname>Mineo</surname><given-names>TC</given-names></name><name><surname>Ottaviani</surname><given-names>F</given-names></name><etal/></person-group><article-title>Meta-analysis of recurrent laryngeal nerve injury in thyroid surgery with or without intraoperative nerve monitoring</article-title><source>Acta Otorhinolaryngol Ital</source><year>2014</year><volume>34</volume><issue>4</issue><fpage>223</fpage><lpage>229</lpage><pub-id pub-id-type="pmid">25210215</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Rulli F, Ambrogi V, Dionigi G, Amirhassankhani S, Mineo TC, Ottaviani F, et al. Meta-analysis of recurrent laryngeal nerve injury in thyroid surgery with or without intraoperative nerve monitoring. Acta Otorhinolaryngol Ital. 2014;34(4):223&#x02013;9.<pub-id pub-id-type="pmid">25210215</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>MY</given-names></name><name><surname>Lee</surname><given-names>JM</given-names></name><name><surname>Won</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>TY</given-names></name><name><surname>Wu</surname><given-names>CW</given-names></name><name><surname>Dionigi</surname><given-names>G</given-names></name><etal/></person-group><article-title>Investigation of potential neuropharmacological activity of neostigmine-glycopyrrolate for intraoperative neural monitoring in thyroid surgery</article-title><source>Kaohsiung J Med Sci</source><year>2022</year><volume>38</volume><issue>1</issue><fpage>59</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1002/kjm2.12448</pub-id><pub-id pub-id-type="pmid">34562340</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Oh MY, Lee JM, Won D, Huang TY, Wu CW, Dionigi G, et al. Investigation of potential neuropharmacological activity of neostigmine-glycopyrrolate for intraoperative neural monitoring in thyroid surgery. Kaohsiung J Med Sci. 2022;38(1):59&#x02013;64.<pub-id pub-id-type="pmid">34562340</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><collab>Fundakowski CE</collab><name><surname>Hales</surname><given-names>NW</given-names></name><name><surname>Agrawal</surname><given-names>N</given-names></name><name><surname>Barczynski</surname><given-names>M</given-names></name><name><surname>Camacho</surname><given-names>PM</given-names></name><name><surname>Hartl</surname><given-names>DM</given-names></name><etal/></person-group><article-title>Surgical management of the recurrent laryngeal nerve in thyroidectomy: American Head and Neck Society Consensus Statement</article-title><source>Head Neck</source><year>2018</year><volume>40</volume><issue>4</issue><fpage>663</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1002/hed.24928</pub-id><pub-id pub-id-type="pmid">29461666</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Fundakowski CE, Hales NW, Agrawal N, Barczynski M, Camacho PM, Hartl DM, et al. Surgical management of the recurrent laryngeal nerve in thyroidectomy: American Head and Neck Society Consensus Statement. Head Neck. 2018;40(4):663&#x02013;75.<pub-id pub-id-type="pmid">29461666</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Anuwong</surname><given-names>A</given-names></name><name><surname>Lavazza</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>HY</given-names></name><name><surname>Wu</surname><given-names>CW</given-names></name><name><surname>Rausei</surname><given-names>S</given-names></name><name><surname>Pappalardo</surname><given-names>V</given-names></name><etal/></person-group><article-title>Recurrent laryngeal nerve management in thyroid surgery: consequences of routine visualization, application of intermittent, standardized and continuous nerve monitoring</article-title><source>Updates Surg</source><year>2016</year><volume>68</volume><issue>4</issue><fpage>331</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1007/s13304-016-0393-9</pub-id><pub-id pub-id-type="pmid">27651334</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Anuwong A, Lavazza M, Kim HY, Wu CW, Rausei S, Pappalardo V, et al. Recurrent laryngeal nerve management in thyroid surgery: consequences of routine visualization, application of intermittent, standardized and continuous nerve monitoring. Updates Surg. 2016;68(4):331&#x02013;41.<pub-id pub-id-type="pmid">27651334</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Randolph</surname><given-names>GW</given-names></name><name><surname>Kamani</surname><given-names>D</given-names></name></person-group><article-title>Intraoperative electrophysiologic monitoring of the recurrent laryngeal nerve during thyroid and parathyroid surgery: experience with 1381 nerves at risk</article-title><source>Laryngoscope</source><year>2017</year><volume>127</volume><issue>1</issue><fpage>280</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1002/lary.26166</pub-id><pub-id pub-id-type="pmid">27389369</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Randolph GW, Kamani D. Intraoperative electrophysiologic monitoring of the recurrent laryngeal nerve during thyroid and parathyroid surgery: experience with 1381 nerves at risk. Laryngoscope. 2017;127(1):280&#x02013;6.<pub-id pub-id-type="pmid">27389369</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Abdelhamid</surname><given-names>A</given-names></name><name><surname>Aspinall</surname><given-names>S</given-names></name></person-group><article-title>Intraoperative nerve monitoring in thyroid surgery: analysis of United Kingdom registry of endocrine and thyroid surgery database</article-title><source>Br J Surg</source><year>2021</year><volume>108</volume><issue>2</issue><fpage>182</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1093/bjs/znaa081</pub-id><pub-id pub-id-type="pmid">33711146</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Abdelhamid A, Aspinall S. Intraoperative nerve monitoring in thyroid surgery: analysis of United Kingdom registry of endocrine and thyroid surgery database. Br J Surg. 2021;108(2):182&#x02013;7.<pub-id pub-id-type="pmid">33711146</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name></person-group><article-title>Protective effects of intraoperative nerve monitoring (ionm) for recurrent laryngeal nerve injury in thyroidectomy: meta-analysis</article-title><source>Sci Rep</source><year>2018</year><volume>8</volume><issue>1</issue><fpage>7761</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-26219-5</pub-id><pub-id pub-id-type="pmid">29773852</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Bai B, Chen W. Protective effects of intraoperative nerve monitoring (ionm) for recurrent laryngeal nerve injury in thyroidectomy: meta-analysis. Sci Rep. 2018;8(1):7761.<pub-id pub-id-type="pmid">29773852</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Beldi</surname><given-names>G</given-names></name><name><surname>Kinsbergen</surname><given-names>T</given-names></name><name><surname>Schlumpf</surname><given-names>R</given-names></name></person-group><article-title>Evaluation of intraoperative recurrent nerve monitoring in thyroid surgery</article-title><source>World J Surg</source><year>2004</year><volume>28</volume><issue>6</issue><fpage>589</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1007/s00268-004-7226-6</pub-id><pub-id pub-id-type="pmid">15366750</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Beldi G, Kinsbergen T, Schlumpf R. Evaluation of intraoperative recurrent nerve monitoring in thyroid surgery. World J Surg. 2004;28(6):589&#x02013;91.<pub-id pub-id-type="pmid">15366750</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Zeng</surname><given-names>M</given-names></name><name><surname>He</surname><given-names>J</given-names></name></person-group><article-title>Effect of intraoperative neuromonitoring on recurrent laryngeal nerve palsy rates after thyroid surgery&#x02013;a meta-analysis</article-title><source>J Formos Med Assoc</source><year>2013</year><volume>112</volume><issue>8</issue><fpage>463</fpage><lpage>472</lpage><pub-id pub-id-type="doi">10.1016/j.jfma.2012.03.003</pub-id><pub-id pub-id-type="pmid">24016611</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Zheng S, Xu Z, Wei Y, Zeng M, He J. Effect of intraoperative neuromonitoring on recurrent laryngeal nerve palsy rates after thyroid surgery&#x02013;a meta-analysis. J Formos Med Assoc. 2013;112(8):463&#x02013;72.<pub-id pub-id-type="pmid">24016611</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Atallah</surname><given-names>I</given-names></name><name><surname>Dupret</surname><given-names>A</given-names></name><name><surname>Carpentier</surname><given-names>AS</given-names></name><name><surname>Weingertner</surname><given-names>AS</given-names></name><name><surname>Volkmar</surname><given-names>PP</given-names></name><name><surname>Rodier</surname><given-names>JF</given-names></name></person-group><article-title>Role of intraoperative neuromonitoring of the recurrent laryngeal nerve in high-risk thyroid surgery</article-title><source>J Otolaryngol Head Neck Surg</source><year>2009</year><volume>38</volume><issue>6</issue><fpage>613</fpage><lpage>618</lpage><pub-id pub-id-type="pmid">19958722</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Atallah I, Dupret A, Carpentier AS, Weingertner AS, Volkmar PP, Rodier JF. Role of intraoperative neuromonitoring of the recurrent laryngeal nerve in high-risk thyroid surgery. J Otolaryngol Head Neck Surg. 2009;38(6):613&#x02013;8.<pub-id pub-id-type="pmid">19958722</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>CW</given-names></name><name><surname>Huang</surname><given-names>TY</given-names></name><name><surname>Randolph</surname><given-names>GW</given-names></name><name><surname>Barczynski</surname><given-names>M</given-names></name><name><surname>Schneider</surname><given-names>R</given-names></name><name><surname>Chiang</surname><given-names>FY</given-names></name><etal/></person-group><article-title>Informed consent for intraoperative neural monitoring in thyroid and parathyroid surgery - consensus statement of the international neural monitoring study group</article-title><source>Front Endocrinol (Lausanne)</source><year>2021</year><volume>12</volume><fpage>795281</fpage><pub-id pub-id-type="doi">10.3389/fendo.2021.795281</pub-id><pub-id pub-id-type="pmid">34950109</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Wu CW, Huang TY, Randolph GW, Barczynski M, Schneider R, Chiang FY, et al. Informed consent for intraoperative neural monitoring in thyroid and parathyroid surgery - consensus statement of the international neural monitoring study group. Front Endocrinol (Lausanne). 2021;12: 795281.<pub-id pub-id-type="pmid">34950109</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>HY</given-names></name><name><surname>Carcoforo</surname><given-names>P</given-names></name><name><surname>Dionigi</surname><given-names>G</given-names></name></person-group><article-title>Cost and training are diffusion patterns limits for neural monitoring in thyroid surgery</article-title><source>Gland Surg</source><year>2019</year><volume>8</volume><issue>4</issue><fpage>334</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.21037/gs.2018.11.08</pub-id><pub-id pub-id-type="pmid">31538633</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Sun H, Kim HY, Carcoforo P, Dionigi G. Cost and training are diffusion patterns limits for neural monitoring in thyroid surgery. Gland Surg. 2019;8(4):334&#x02013;5.<pub-id pub-id-type="pmid">31538633</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Randolph</surname><given-names>GW</given-names></name><name><surname>Dralle</surname><given-names>H</given-names></name><collab>International Intraoperative Monitoring Study</collab><name><surname>Abdullah</surname><given-names>H</given-names></name><name><surname>Barczynski</surname><given-names>M</given-names></name><name><surname>Bellantone</surname><given-names>R</given-names></name><etal/></person-group><article-title>Electrophysiologic recurrent laryngeal nerve monitoring during thyroid and parathyroid surgery: international standards guideline statement</article-title><source>Laryngoscope.</source><year>2011</year><volume>121</volume><issue>Suppl 1</issue><fpage>S1</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">21181860</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Randolph GW, Dralle H, International Intraoperative Monitoring Study, Abdullah H, Barczynski M, Bellantone R, et al. Electrophysiologic recurrent laryngeal nerve monitoring during thyroid and parathyroid surgery: international standards guideline statement. Laryngoscope. 2011;121(Suppl 1):S1-16.<pub-id pub-id-type="pmid">21181860</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="book"><person-group person-group-type="author"><name><surname>Tuttle</surname><given-names>MML</given-names></name><name><surname>Haugen</surname><given-names>B</given-names></name><name><surname>Shah</surname><given-names>J</given-names></name><name><surname>Sosa</surname><given-names>JA</given-names></name><name><surname>Rohren</surname><given-names>E</given-names></name><name><surname>Subramaniam</surname><given-names>RM</given-names></name><name><surname>Hunt</surname><given-names>JL</given-names></name><name><surname>Perrier</surname><given-names>ND</given-names></name></person-group><source>Thyroid differentiated and anaplastic carcinoma (Chapter 73)</source><year>2017</year><publisher-loc>New York</publisher-loc><publisher-name>Springer International Publishing</publisher-name></element-citation><mixed-citation id="mc-CR16" publication-type="book">Tuttle MML, Haugen B, Shah J, Sosa JA, Rohren E, Subramaniam RM, Hunt JL, Perrier ND. Thyroid differentiated and anaplastic carcinoma (Chapter 73). New York: Springer International Publishing; 2017.</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>FY</given-names></name><name><surname>Lu</surname><given-names>IC</given-names></name><name><surname>Kuo</surname><given-names>WR</given-names></name><name><surname>Lee</surname><given-names>KW</given-names></name><name><surname>Chang</surname><given-names>NC</given-names></name><name><surname>Wu</surname><given-names>CW</given-names></name></person-group><article-title>The mechanism of recurrent laryngeal nerve injury during thyroid surgery&#x02013;the application of intraoperative neuromonitoring</article-title><source>Surgery</source><year>2008</year><volume>143</volume><issue>6</issue><fpage>743</fpage><lpage>749</lpage><pub-id pub-id-type="doi">10.1016/j.surg.2008.02.006</pub-id><pub-id pub-id-type="pmid">18549890</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Chiang FY, Lu IC, Kuo WR, Lee KW, Chang NC, Wu CW. The mechanism of recurrent laryngeal nerve injury during thyroid surgery&#x02013;the application of intraoperative neuromonitoring. Surgery. 2008;143(6):743&#x02013;9.<pub-id pub-id-type="pmid">18549890</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Snyder</surname><given-names>SK</given-names></name><name><surname>Lairmore</surname><given-names>TC</given-names></name><name><surname>Hendricks</surname><given-names>JC</given-names></name><name><surname>Roberts</surname><given-names>JW</given-names></name></person-group><article-title>Elucidating mechanisms of recurrent laryngeal nerve injury during thyroidectomy and parathyroidectomy</article-title><source>J Am Coll Surg</source><year>2008</year><volume>206</volume><issue>1</issue><fpage>123</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1016/j.jamcollsurg.2007.07.017</pub-id><pub-id pub-id-type="pmid">18155577</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Snyder SK, Lairmore TC, Hendricks JC, Roberts JW. Elucidating mechanisms of recurrent laryngeal nerve injury during thyroidectomy and parathyroidectomy. J Am Coll Surg. 2008;206(1):123&#x02013;30.<pub-id pub-id-type="pmid">18155577</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Cirocchi</surname><given-names>R</given-names></name><name><surname>Arezzo</surname><given-names>A</given-names></name><name><surname>D&#x02019;Andrea</surname><given-names>V</given-names></name><name><surname>Abraha</surname><given-names>I</given-names></name><name><surname>Popivanov</surname><given-names>GI</given-names></name><name><surname>Avenia</surname><given-names>N</given-names></name><etal/></person-group><article-title>Intraoperative neuromonitoring versus visual nerve identification for prevention of recurrent laryngeal nerve injury in adults undergoing thyroid surgery</article-title><source>Cochrane Database Syst Rev.</source><year>2019</year><volume>1</volume><issue>1</issue><fpage>CD012483</fpage><pub-id pub-id-type="pmid">30659577</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Cirocchi R, Arezzo A, D&#x02019;Andrea V, Abraha I, Popivanov GI, Avenia N, et al. Intraoperative neuromonitoring versus visual nerve identification for prevention of recurrent laryngeal nerve injury in adults undergoing thyroid surgery. Cochrane Database Syst Rev. 2019;1(1):CD012483.<pub-id pub-id-type="pmid">30659577</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Davey</surname><given-names>MG</given-names></name><name><surname>Cleere</surname><given-names>EF</given-names></name><name><surname>Lowery</surname><given-names>AJ</given-names></name><name><surname>Kerin</surname><given-names>MJ</given-names></name></person-group><article-title>Intraoperative recurrent laryngeal nerve monitoring versus visualisation alone - A systematic review and meta-analysis of randomized controlled trials</article-title><source>Am J Surg</source><year>2022</year><volume>224</volume><issue>3</issue><fpage>836</fpage><lpage>841</lpage><pub-id pub-id-type="doi">10.1016/j.amjsurg.2022.03.036</pub-id><pub-id pub-id-type="pmid">35422329</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Davey MG, Cleere EF, Lowery AJ, Kerin MJ. Intraoperative recurrent laryngeal nerve monitoring versus visualisation alone - A systematic review and meta-analysis of randomized controlled trials. Am J Surg. 2022;224(3):836&#x02013;41.<pub-id pub-id-type="pmid">35422329</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Henry</surname><given-names>BM</given-names></name><name><surname>Graves</surname><given-names>MJ</given-names></name><name><surname>Vikse</surname><given-names>J</given-names></name><name><surname>Sanna</surname><given-names>B</given-names></name><name><surname>Pekala</surname><given-names>PA</given-names></name><name><surname>Walocha</surname><given-names>JA</given-names></name><etal/></person-group><article-title>The current state of intermittent intraoperative neural monitoring for prevention of recurrent laryngeal nerve injury during thyroidectomy: a PRISMA-compliant systematic review of overlapping meta-analyses</article-title><source>Langenbecks Arch Surg</source><year>2017</year><volume>402</volume><issue>4</issue><fpage>663</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.1007/s00423-017-1580-y</pub-id><pub-id pub-id-type="pmid">28378238</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Henry BM, Graves MJ, Vikse J, Sanna B, Pekala PA, Walocha JA, et al. The current state of intermittent intraoperative neural monitoring for prevention of recurrent laryngeal nerve injury during thyroidectomy: a PRISMA-compliant systematic review of overlapping meta-analyses. Langenbecks Arch Surg. 2017;402(4):663&#x02013;73.<pub-id pub-id-type="pmid">28378238</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Malik</surname><given-names>R</given-names></name><name><surname>Linos</surname><given-names>D</given-names></name></person-group><article-title>Intraoperative neuromonitoring in thyroid surgery: a systematic review</article-title><source>World J Surg</source><year>2016</year><volume>40</volume><issue>8</issue><fpage>2051</fpage><lpage>2058</lpage><pub-id pub-id-type="doi">10.1007/s00268-016-3594-y</pub-id><pub-id pub-id-type="pmid">27329143</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Malik R, Linos D. Intraoperative neuromonitoring in thyroid surgery: a systematic review. World J Surg. 2016;40(8):2051&#x02013;8.<pub-id pub-id-type="pmid">27329143</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Pisanu</surname><given-names>A</given-names></name><name><surname>Porceddu</surname><given-names>G</given-names></name><name><surname>Podda</surname><given-names>M</given-names></name><name><surname>Cois</surname><given-names>A</given-names></name><name><surname>Uccheddu</surname><given-names>A</given-names></name></person-group><article-title>Systematic review with meta-analysis of studies comparing intraoperative neuromonitoring of recurrent laryngeal nerves versus visualization alone during thyroidectomy</article-title><source>J Surg Res</source><year>2014</year><volume>188</volume><issue>1</issue><fpage>152</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1016/j.jss.2013.12.022</pub-id><pub-id pub-id-type="pmid">24433869</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Pisanu A, Porceddu G, Podda M, Cois A, Uccheddu A. Systematic review with meta-analysis of studies comparing intraoperative neuromonitoring of recurrent laryngeal nerves versus visualization alone during thyroidectomy. J Surg Res. 2014;188(1):152&#x02013;61.<pub-id pub-id-type="pmid">24433869</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Dralle</surname><given-names>H</given-names></name><name><surname>Sekulla</surname><given-names>C</given-names></name><name><surname>Haerting</surname><given-names>J</given-names></name><name><surname>Timmermann</surname><given-names>W</given-names></name><name><surname>Neumann</surname><given-names>HJ</given-names></name><name><surname>Kruse</surname><given-names>E</given-names></name><etal/></person-group><article-title>Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery</article-title><source>Surgery</source><year>2004</year><volume>136</volume><issue>6</issue><fpage>1310</fpage><lpage>1322</lpage><pub-id pub-id-type="doi">10.1016/j.surg.2004.07.018</pub-id><pub-id pub-id-type="pmid">15657592</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Dralle H, Sekulla C, Haerting J, Timmermann W, Neumann HJ, Kruse E, et al. Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery. Surgery. 2004;136(6):1310&#x02013;22.<pub-id pub-id-type="pmid">15657592</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Sanabria</surname><given-names>A</given-names></name><name><surname>Ramirez</surname><given-names>A</given-names></name><name><surname>Kowalski</surname><given-names>LP</given-names></name><name><surname>Silver</surname><given-names>CE</given-names></name><name><surname>Shaha</surname><given-names>AR</given-names></name><name><surname>Owen</surname><given-names>RP</given-names></name><etal/></person-group><article-title>Neuromonitoring in thyroidectomy: a meta-analysis of effectiveness from randomized controlled trials</article-title><source>Eur Arch Otorhinolaryngol</source><year>2013</year><volume>270</volume><issue>8</issue><fpage>2175</fpage><lpage>2189</lpage><pub-id pub-id-type="doi">10.1007/s00405-013-2557-2</pub-id><pub-id pub-id-type="pmid">23681545</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Sanabria A, Ramirez A, Kowalski LP, Silver CE, Shaha AR, Owen RP, et al. Neuromonitoring in thyroidectomy: a meta-analysis of effectiveness from randomized controlled trials. Eur Arch Otorhinolaryngol. 2013;270(8):2175&#x02013;89.<pub-id pub-id-type="pmid">23681545</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Wojtczak</surname><given-names>B</given-names></name><name><surname>Marciniak</surname><given-names>D</given-names></name><name><surname>Kaliszewski</surname><given-names>K</given-names></name><name><surname>Sutkowski</surname><given-names>K</given-names></name><name><surname>Glod</surname><given-names>M</given-names></name><name><surname>Rudnicki</surname><given-names>J</given-names></name><etal/></person-group><article-title>Proving the superiority of intraoperative recurrent laryngeal nerve monitoring over visualization alone during thyroidectomy</article-title><source>Biomedicines.</source><year>2023</year><volume>11</volume><issue>3</issue><fpage>880</fpage><pub-id pub-id-type="doi">10.3390/biomedicines11030880</pub-id><pub-id pub-id-type="pmid">36979859</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Wojtczak B, Marciniak D, Kaliszewski K, Sutkowski K, Glod M, Rudnicki J, et al. Proving the superiority of intraoperative recurrent laryngeal nerve monitoring over visualization alone during thyroidectomy. Biomedicines. 2023;11(3):880.<pub-id pub-id-type="pmid">36979859</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Donatini</surname><given-names>G</given-names></name><name><surname>Danion</surname><given-names>J</given-names></name><name><surname>Zerrweck</surname><given-names>C</given-names></name><name><surname>Etienne</surname><given-names>P</given-names></name><name><surname>Lacoste</surname><given-names>L</given-names></name><name><surname>Kraimps</surname><given-names>JL</given-names></name></person-group><article-title>Single dose steroid injection after loss of signal (LOS) during thyroid surgery is effective to recover electric signal avoiding vocal cord palsy and the need of staged thyroidectomy: prospective evaluation on 702 patients</article-title><source>World J Surg</source><year>2020</year><volume>44</volume><issue>2</issue><fpage>417</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1007/s00268-019-05295-2</pub-id><pub-id pub-id-type="pmid">31741073</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Donatini G, Danion J, Zerrweck C, Etienne P, Lacoste L, Kraimps JL. Single dose steroid injection after loss of signal (LOS) during thyroid surgery is effective to recover electric signal avoiding vocal cord palsy and the need of staged thyroidectomy: prospective evaluation on 702 patients. World J Surg. 2020;44(2):417&#x02013;25.<pub-id pub-id-type="pmid">31741073</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Iscan</surname><given-names>Y</given-names></name><name><surname>Aygun</surname><given-names>N</given-names></name><name><surname>Sormaz</surname><given-names>IC</given-names></name><name><surname>Tunca</surname><given-names>F</given-names></name><name><surname>Uludag</surname><given-names>M</given-names></name><name><surname>Senyurek</surname><given-names>YG</given-names></name></person-group><article-title>Is craniocaudal dissection of recurrent laryngeal nerve safer than lateral approach: a prospective randomized study comparing both techniques by using continuous intraoperative nerve monitoring</article-title><source>Ann Surg Treat Res</source><year>2022</year><volume>103</volume><issue>4</issue><fpage>205</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.4174/astr.2022.103.4.205</pub-id><pub-id pub-id-type="pmid">36304193</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Iscan Y, Aygun N, Sormaz IC, Tunca F, Uludag M, Senyurek YG. Is craniocaudal dissection of recurrent laryngeal nerve safer than lateral approach: a prospective randomized study comparing both techniques by using continuous intraoperative nerve monitoring. Ann Surg Treat Res. 2022;103(4):205&#x02013;16.<pub-id pub-id-type="pmid">36304193</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Pragacz</surname><given-names>K</given-names></name><name><surname>Barczynski</surname><given-names>M</given-names></name></person-group><article-title>Evaluation of the learning curve for intraoperative neural monitoring of the recurrent laryngeal nerves in thyroid surgery</article-title><source>Pol Przegl Chir</source><year>2015</year><volume>86</volume><issue>12</issue><fpage>584</fpage><lpage>593</lpage><pub-id pub-id-type="doi">10.1515/pjs-2015-0005</pub-id><pub-id pub-id-type="pmid">25803058</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Pragacz K, Barczynski M. Evaluation of the learning curve for intraoperative neural monitoring of the recurrent laryngeal nerves in thyroid surgery. Pol Przegl Chir. 2015;86(12):584&#x02013;93.<pub-id pub-id-type="pmid">25803058</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Wojtczak</surname><given-names>B</given-names></name><name><surname>Sutkowski</surname><given-names>K</given-names></name><name><surname>Kaliszewski</surname><given-names>K</given-names></name><name><surname>Glod</surname><given-names>M</given-names></name><name><surname>Barczynski</surname><given-names>M</given-names></name></person-group><article-title>Experience with intraoperative neuromonitoring of the recurrent laryngeal nerve improves surgical skills and outcomes of non-monitored thyroidectomy</article-title><source>Langenbecks Arch Surg</source><year>2017</year><volume>402</volume><issue>4</issue><fpage>709</fpage><lpage>717</lpage><pub-id pub-id-type="doi">10.1007/s00423-016-1449-5</pub-id><pub-id pub-id-type="pmid">27209315</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Wojtczak B, Sutkowski K, Kaliszewski K, Glod M, Barczynski M. Experience with intraoperative neuromonitoring of the recurrent laryngeal nerve improves surgical skills and outcomes of non-monitored thyroidectomy. Langenbecks Arch Surg. 2017;402(4):709&#x02013;17.<pub-id pub-id-type="pmid">27209315</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Duclos</surname><given-names>A</given-names></name><name><surname>Peix</surname><given-names>JL</given-names></name><name><surname>Colin</surname><given-names>C</given-names></name><name><surname>Kraimps</surname><given-names>JL</given-names></name><name><surname>Menegaux</surname><given-names>F</given-names></name><name><surname>Pattou</surname><given-names>F</given-names></name><etal/></person-group><article-title>Influence of experience on performance of individual surgeons in thyroid surgery: prospective cross sectional multicentre study</article-title><source>BMJ</source><year>2012</year><volume>344</volume><fpage>d8041</fpage><pub-id pub-id-type="doi">10.1136/bmj.d8041</pub-id><pub-id pub-id-type="pmid">22236412</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Duclos A, Peix JL, Colin C, Kraimps JL, Menegaux F, Pattou F, et al. Influence of experience on performance of individual surgeons in thyroid surgery: prospective cross sectional multicentre study. BMJ. 2012;344: d8041.<pub-id pub-id-type="pmid">22236412</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Kotan</surname><given-names>C</given-names></name><name><surname>Kosem</surname><given-names>M</given-names></name><name><surname>Algun</surname><given-names>E</given-names></name><name><surname>Ayakta</surname><given-names>H</given-names></name><name><surname>Sonmez</surname><given-names>R</given-names></name><name><surname>Soylemez</surname><given-names>O</given-names></name></person-group><article-title>Influence of the refinement of surgical technique and surgeon&#x02019;s experience on the rate of complications after total thyroidectomy for benign thyroid disease</article-title><source>Acta Chir Belg</source><year>2003</year><volume>103</volume><issue>3</issue><fpage>278</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1080/00015458.2003.11679423</pub-id><pub-id pub-id-type="pmid">12914362</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Kotan C, Kosem M, Algun E, Ayakta H, Sonmez R, Soylemez O. Influence of the refinement of surgical technique and surgeon&#x02019;s experience on the rate of complications after total thyroidectomy for benign thyroid disease. Acta Chir Belg. 2003;103(3):278&#x02013;81.<pub-id pub-id-type="pmid">12914362</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Snyder</surname><given-names>SK</given-names></name><name><surname>Sigmond</surname><given-names>BR</given-names></name><name><surname>Lairmore</surname><given-names>TC</given-names></name><name><surname>Govednik-Horny</surname><given-names>CM</given-names></name><name><surname>Janicek</surname><given-names>AK</given-names></name><name><surname>Jupiter</surname><given-names>DC</given-names></name></person-group><article-title>The long-term impact of routine intraoperative nerve monitoring during thyroid and parathyroid surgery</article-title><source>Surgery</source><year>2013</year><volume>154</volume><issue>4</issue><fpage>704</fpage><lpage>711</lpage><pub-id pub-id-type="doi">10.1016/j.surg.2013.06.039</pub-id><pub-id pub-id-type="pmid">24008089</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Snyder SK, Sigmond BR, Lairmore TC, Govednik-Horny CM, Janicek AK, Jupiter DC. The long-term impact of routine intraoperative nerve monitoring during thyroid and parathyroid surgery. Surgery. 2013;154(4):704&#x02013;11.<pub-id pub-id-type="pmid">24008089</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Haugen</surname><given-names>BR</given-names></name><name><surname>Alexander</surname><given-names>EK</given-names></name><name><surname>Bible</surname><given-names>KC</given-names></name><name><surname>Doherty</surname><given-names>GM</given-names></name><name><surname>Mandel</surname><given-names>SJ</given-names></name><name><surname>Nikiforov</surname><given-names>YE</given-names></name><etal/></person-group><article-title>2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer</article-title><source>Thyroid</source><year>2016</year><volume>26</volume><issue>1</issue><fpage>1</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1089/thy.2015.0020</pub-id><pub-id pub-id-type="pmid">26462967</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1&#x02013;133.<pub-id pub-id-type="pmid">26462967</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>